http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
국내에서 유행하는 HIV의 전파 경로에 따른 Subtype 분포
이주실,남정구,김성순,강춘,최병선,김옥진,박미선,성봉모,서순덕,전수경,변승옥,신영오,조해월 대한감염학회 2001 감염 Vol.33 No.5
Background : Previous data have been reported that subtype B is prevalent in South Korea, but neither the extent nor the proportion of subtypes could be evaluated. This study was designed to analyze the distribution of HIV-1 subtypes, temporal instructions and transmission dynamics between epidemiological groups. Methods : 1,280 Koreans had been diagnosed as HIV seropositive during the period 1985 to 2000. Among them, 134 individuals were selected for this molecular epidemiological study. 134 DNAs were isolated from uncultured or cultured peripheral blood mononuclear cells. V3-V5 (0.7 kb) fragment of HIV-1 env gene was amplified by nested polymerase chain reaction and was sequenced. Results : HIV-1 isolates from thirty-seven homosexuals were all subtype B (100%). On the other hand, 66 isolates from 94 heterosexuals were subtype B (70%) and 28 were non B subtypes (30% : 13 A, 4 C, 2 D, 8 E , 1 G). Only subtype B strains were isolated from 73 males who were infected with HIV inside Korea while 16 B and 20 non B subtype strains were isolated from 36 males who were HIV infected outside of Korea. However, B and non B strains were isolated half and half from females who were infected inside Korea except one. Conclusion : The HIV-1 subtype B strains are prevalent in Korea from the early HIV infection until present in both homo and heterosexuals. Non B strains have been transmitted from men who were infected outside Korea to their spouses and casual partners. So, we need further study to monitor subtype B and non B HIV transmission in epidemiological groups of Korea, (Korean J Infect Dis 33:311∼318, 2001)
황해 동남 해역의 수괴지표성 요각류 및 모악류의 분포와 수괴특성
박주석,이삼석,강영실,이병돈,허성회 동의대학교 기초과학연구소 1993 基礎科學硏究論文集 Vol.3 No.1
Distribution of indicator species of copepods and chaetognaths were studied as an indicator species of water mass in the southeastern area of the Yellow Sea. Undinula darwini, Lucicutia flavicornis, Pleuromamma gracilis, Euchaeta resselli, Euchaeta plana and Sagitta enflata were found to be reliable indicator species for determining warm water mass. Of these species, E. plana and E. russelli have a weak tolerance on the low temperature. Sagitta crassa was indicator species of neritic waters: Sagitta bedoti was that of mixing waters. Centropages agdominalis represented neritic cold waters. In February U. darwini, L. flavicornis, P. gracilis, E. russelli, E. plana and S. enflata occurred in the western waters of Cheju-Do where warm waters over 14℃ occupied. Centropages abdominalis occurred in the northern area beyond Chindo with water temperature less than 10℃. E. plana, E. russelli and S. bedoti were found at the regions between Cheju-Do and Chindo where the water temperature was 12∼14℃ corresponding to the mixing waters. Based on cluster analysis and T-S diagram in February three different water masses were identified from the south to the north. In August, water masses were analyzed at two different layers, 0∼20m and 20m∼bottom layers, separated by thermocline depth. In 0∼20m layer, E plana and E. russelli were found from the western waters of Cheju-Do to Daehuksando. In 20m∼bottom layer, E. russelli and E. plana occurred at the northwestern waters of Cheju-Do with the water temperature warmer than 12℃. C. abdominalis was found at the northern area beyond Chindo. Based on the cluster analysis and T-S diagram in August three different water masses at 0∼20m and 20m∼bottom layers were identified from the coast to the offshore. C. abdominalis was found at the adjacent water of Chindo at 0∼20m layer and the northern area beyond Chindo at 20m∼bottom layer. This fact suggested that the cold water mass existed at the adjacent waters of Chindo in summer.
Lee, Suk-Kyeong,Lee, Sun-A,Byun, Hye-sin,Cho, Mi-La,Kim, Wan-Uk,Park, Sung-Hwan,Cho, Chul-Soo,Joo, Yeong-Shil,Lee, Shin-Seok,Yoo, Eun-Sook,Son, Ho-Jung,Kim, Ho-Youn THE CATHOLIC UNIVERSITY OF KOREA 2000 Bulletin of The Catholic Research Institutes of Me Vol.28 No.-
The therapeutic potential of phosphodiesterase 4 (PDE4) inhibitors in inflammatory diseases including some autoimmune diseases has been explored recently with some hopeful results. These PDE4 inhibitors are thought to show their anti-inflammatory effect by down-regulating tumor necrosis factor-α (TNF -α) production in lymphocytes and macrophages. A high concentration of TNF -α have been found in rheumatoid arthritis (RA) synovium and reducing TNF -α using biological agents was proven to be an effective RA treatment. To test the possibility of using PDE4 inhibitors for RA treatment, the effects of a newly synthesized PDE4 inhibitor, DWP205505, on TNF -α and IL-10 production was tested in cells isolated from normal peripheral blood and rheumatoid arthritis synovial fluid. Cytokine production was assayed at the protein level by sandwich enzyme-linked immunosorbent assay (ELISA) and at the mRNA expression level by semi-quantitative RT-PCR. Another PDE4 inhibitor, RP73401, was used for comparison. DWP205505 and RP73401 had no harmful effect on cell viability up to 10 μM concentration during the 24 hour culture period. DWP205505 as well as RP73401 significantly reduced TNF -α secretion from both unstimulated and lipopolysaccharide (LPS)-stimulated perpheral blood mononuclear cells (PBMC) and synovial fluid mononuclear cells (SFMC). The effect of DWP205505 or RP73401 treatment on the mRNA expression of TNF -α was also studied in LPS-stimulated PBMC and SFMC. TNF -α mRNA expression was increased by LPS stimulation and both of the PDE4 inhibitors suppressed TNF -α mRNA expression. For interleukin-10 (IL-10), a little different results were obtained from PBMC and SFMC; IL-10 secretion was unaffected by LPS stimulation and only minimally affected by both of the PDE4 inhibitors in PBMC. In unstimulated SFMC, DWP205505 and RP73401 slightly enhanced IL-10 secretion, while they reduced IL-10 secretion from LPS-stimulated SFMC where IL-10 secretion was a lot higher than unstimulated SFMC. These results suggest that the newly synthesized PDE4 inhibitor DWP205505 may have anti-rheumatioid arthritis activity. (Journal of Microbiology and Biotechnology 9(1):106-112, 1999)
Rapid Dissemination of Newly Introduced Plasmodium vivax Genotypes in South Korea
Kim, Yeon-Joo,Kim, Jung-Yeon,Lee, Eun-Gyu,Lee, Byeong-Chul,Cho, Shin-Hyung,Yu, Jae-Ran,Rhie, Ho-Gun,Choi, Yien-Kyoung,Lee, Ho-Sa,Lee, Joo-Shil,Kim, Tong-Soo,Choi, Kyung-Mi,Park, Mi-Hyun American Society of Tropical Medicine and Hygiene 2010 The American journal of tropical medicine and hygi Vol.82 No.3
<P>Reemerged Plasmodium vivax malaria in South Korea has not yet been eradicated despite continuous governmental efforts. It has rather become an endemic disease. Our study aimed to determine the genetic diversity in P. vivax merozoite surface protein-1 (PvMSP-1) and circumsporozoite protein (PvCSP) genes over an extended period after its reemergence to its current status. Sequence analysis of PvMSP-1 gene sequences from the 632 P. vivax isolates during 1996-2007 indicates that most isolates recently obtained were different from isolates obtained in the initial reemergence period. There was initially only one subtype (recombinant) present but its subtypes have varied since 2000; six MSP-1 subtypes were recently found. A similar variation was observed by CSP gene analysis; a new CSP subtype was found. Understanding genetic variation patterns of the parasite may help to analyze trends and assess extent of endemic malaria in South Korea.</P>
주영실 ( Yeong Shil Joo ),이신석 ( Shin Seok Lee ),김완욱 ( Wan Uk Kim ),민준기 ( Jun Ki Min ),박성환 ( Sung Hwan Park ),홍연식 ( Yeon Sik Hong ),이상헌 ( Sang Heon Lee ),조철수 ( Chul Soo Cho ),김호연 ( Ho Youn Kim ) 대한류마티스학회 2000 대한류마티스학회지 Vol.7 No.1
Objectives: To assess the extent of generalized osteoporosis in Korean rheumatoid arthritis patients and evaluate the importance of disease activity, duration of disease, menopausal status, corticosteroid use and markers of bone metabolism. Methods: Bone mineral density was measured by dual energy x-ray absorptiometry (DEXA) at 3 locations in 134 rheumatoid arthritis patients, aged 21~80 (57 premenopausal and 66 postmenopausal patients). Markers of bone metabolism were measured and assessed in relation to the disease activity and corticosteroid use. Results: The mean age of the study population was 49 years and mean age of the menopause was 48.1±3.6 years. Decreased bone mineral density was observed at all 3 locations measured in the study population (Z-score -0.36, -0.14 and -0.66 for BMD of L-spine, femoral neck and femur Ward`s triangle respectively). Fifty nine percent of the patients showed osteopenia (T-score <-1) and 13.4% showed Tscore lower than -2.5. The best independent predictors of bone mass (stepweise multiple regression analysis) was body mass index, cortocosteroid use, and CRP in premenopausal patients and years post menopause, age, alkaline phosphatase and rheumatoid factor in postmenopausal patients. Urinary excretion of deoxypyridinoline was increased in both pre- and postmonopausal RA patients while serum osteocalcin level was normal in both groups. Deoxypyridinoline level was significantly correlated with CRP in premenopausal RA patients. Conclusion: Generalized osteoporosis is also prevalent in Korean rheumatoid arthritis patients. Bone metabolism appears to be uncoupled. Deoxypyridinoline correlated best with CRP and thus can provide a rational approach for selecting and treating patients with RA to reduce the risk of osteoporotic fracture.
Lee, Seon-Young,Choi, Byeong-Sun,Kim, Sung Soon,Choi, Su-Mi,Shin, Wan-Shik,Lee, Joo-Shil 대한감염학회 2008 감염과 화학요법 Vol.40 No.3
Human cytomegalovirus (HCMV) is a common human pathogen that causes morbidity and mortality in hematopoietic stem cell transplantation (HSCT) recipients. Early diagnosis of HCMV infection or reactivation, and setting threshold values for effective pre-emptive therapies, are required for appropriate HCMV disease prevention in HSCT recipients. We compared the HCMV infections detected by the two methods, LightCycler-based PCR (LC PCR) and in-house immediate early protein PCR (in-house IE PCR) with the results of a pp65 antigenemia assay as the reference. The sensitivity and specificity for the in-house IE PCR were 79.3% and 72.7%, respectively, and 82.9% and 40.7%, respectively, for the LC PCR. The correlation between the HCMV viral load and pp65 antigenemia in HSCT recipients was r=0.603 with in-house IE PCR and r=0.525 with LC PCR. The discordant results between methods and relatively low (r) values suggest that we need more study to set threshold values according to the using methods with clinical outcome.
Clinical data on treatment regimen and use of medication among patients with hemophilia B in Korea
Park Young Shil,Park Ji Kyoung,Park Jeong A,Baek Hee Jo,Lee Jae Hee,You Chur Woo,Lyu Chuhl Joo,Choi Eun Jin 대한혈액학회 2024 Blood Research Vol.59 No.3
To investigate the clinical treatment status, such as treatment regimen, bleeding events, and drug dose, in patients with hemophilia B in South Korea.In this retrospective chart review, data of patients with hemophilia B from eight university hospitals were collected. Demographic and clinical data, treatment data, such as regimen and number of injections, dose of factor IX concentrate, and bleeding data were reviewed. Descriptive analyses were performed with annual data for 2019, 2020, and 2021, as well as the three years consecutively.The medical records of 150 patients with hemophilia B between January 1, 2019, and December 31, 2021, were collected. Among these, 72 (48.0%) were severe, 47 (31.3%) were moderate, and 28 (18.7%) were mild. The results showed approximately two times more patients receiving prophylaxis as those receiving on-demand therapy, with 66.1% of patients receiving prophylaxis in 2019, 64.9% in 2020, and 72.1% in 2021. Annualized bleeding rates were 2.2% (± 3.1) in 2019, 1.8% (± 3.0) in 2020, and 1.8% (± 2.9) in 2021 among patients receiving prophylaxis. For the doses of factor IX concentrate, patients receiving prophylaxis received an average of 41.6 (± 11.9) IU/Kg/Injection in 2019, 45.7 (± 12.9) IU/Kg/Injection in 2020, and 60.1 (± 24.0) IU/Kg/Injection in 2021.Clinically, prophylaxis is more prevalent than reported. Based on insights gained from current clinical evidence, it is expected that the unmet medical needs of patients can be identified, and physicians can evaluate the status of patients and actively manage hemophilia B using more effective treatment strategies.